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IMPACT OF GENDER ON ACUTE AEROBIC EXERCISE INDUCED BRAIN-

DERIVED NEUROTROPHIC FACTOR AND COGNITIVE FUNCTION
IN OLDER ADULTS

MADISON LEIGH PHILLIPS

ABSTRACT
Purpose: The purpose of this study was to examine the impact of gender on acute exercise
induced BDNF and cognitive function among older individuals. The hypothesis was that
exercise would increase BDNF levels and enhance cognitive processing time post exercise

followed by a drop in BDNF and return cognitive processing time to baseline post-30
minutes. It was also hypothesized that women would have higher BDNF values compared to

men.
Methods: The subjects consisted of 18 active males (n = 9) and females (n = 9). The

subjects took part in an exercise trial and a control trial. The exercise trial entailed riding
either a recumbent or upright bike at 75% of their age predicted max heart rate for 30

minutes. The control trial consisted of reading. A Stroop Test was given, and blood samples

were obtained before, after, and 30 minutes after exercise and control. Serum was analyzed
for BDNF, testosterone, and estrogen using commercially available ELISA kits.
Results: Results showed that there was a significant effect of time in Stroop testing across all

subjects. There was a trend (p = 0.068) for a decrease in Stroop time from pre to immediate-

post timepoints, and a significant decrease (p = 0.004) in Stroop time from pre to post-30
timepoints. There was a significant main effect of exercise on BDNF levels, (p = 0.05) and

females were found to have significantly higher BDNF than males (p = 0.055).

Conclusion: There was statistical evidence that acute exercise affects BDNF production in
both genders, but not cognitive processing speed among an older active population.

Cognitive processing speed continued to improve across all timepoints. As well, women

were found to have overall higher BDNF.
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CHAPTER I

INTRODUCTION
Brain-derived neurotrophic factor (BDNF) is a naturally created neurotrophin that

is distributed throughout many areas of the brain, specifically in the hippocampus which
is where high levels of BDNF are found (Adlard, Perreau, Engessar-Cesar, & Cotman,

2004). It has been found in research that within the hippocampus there is an association
with learning, memory processes, and neural plasticity (Adlard et al., 2004). BDNF

provides support to different subpopulations of neurons in both nuerotrophic and
neuroprotective manners during the development of those neurons across the lifespan
(Adlard et al., 2004). BDNF levels that are deemed low have been linked to many

different types of neuropsychiatric disorders including depression, bipolar disorder,

schizophrenia, and neurodegenerative diseases such as Alzheimer’s disease and
Parkinson’s disease (Begliuomini et al., 2007; Ventriglia et al., 2013). In contrast, it has

been previously reported that exercise significantly increases the amount of BDNF
produced within the brain, in result aiding in cognitive function (Piepmeier & Etnier,

2015).
BDNF is present within the brain as early as fetal life; at birth BDNF intensifies
to a maximal level allowing for neuronal outgrowth and differentiation in neonates

1

(Begliuomini et al., 2007). With aging, the amount of BDNF produced slowly becomes
less over time. BDNF is released in both genders, however specific sex hormones
released by males and females have an impact on the amount of BDNF produced. Fertile
women show significantly higher plasma BDNF levels compared to that of BDNF plasma

levels of postmenopausal women, while amenorrhoeic women have the lowest BDNF

plasma levels (Begliuomini et al., 2007). There are fewer studies on how sex hormones
affect BDNF production in men; however, it has been reported that testosterone, a key
factor of androgens, has an encouraging impact on BDNF expression or reproduction

(Carbone & Honda, 2012). Both genders are said to experience the same age-related
decline of BDNF (Boudewijn et al., 2011).

The tie between sex hormones and that of BDNF production is repetitively found

across all forms of research. In this research there is a common link and influence that
are further determined by the specific physiological and pathological characteristics of

the human subject. Like that of BDNF plasma decreasing with increasing age and weight
in both genders suggesting that gender has no effect on BDNF production when

individuals are the same age and same weight (Lommatzsch, Zingler, Schuhbaeck,
Schloetcke, Zingler, Schuff-Werner, and Virchow 2005). However, these facts should
not defer the interest from the knowledge that overall BDNF levels of men versus women
are different, women have higher BDNF plasma levels than men overall. This supports

the idea that gender, age, weight, and other physiological characteristics do in fact
determine the BDNF production of individuals resulting in some having increased

interest as to how this can be affected with acute bouts of exercise (Lommatzch et al.,

2005).
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In reviewing literature, it is evident that there is a surplus of research studies

designed to advance knowledge on how exercise, specifically acute bouts of exercise,

may affect cognitive performance. Many studies have evaluated specifically cognitive
performance while performing acute exercise through the use of rodents. Mu et al.

(1999) administered neural injections of BDNF into rats, essentially depriving the rats of
their natural secretion of BDNF, in order to prove that BDNF is imperative in aiding in

cognitive function and memory. While other studies have assessed BDNF production
post-exercise and cognitive performance through human subjects. Wiet (2018) assessed
premenopausal and postmenopausal women’s aerobic exercised induced BDNF and

cognitive production via treadmill running through the Stroop test finding that
premenopausal women had a rise in BDNF levels after exercise and postmenopausal
women had a decrease in BDNF levels after exercise (Wiet, 2018). The peripheral

readings of BDNF levels are conducted as a surrogate indicator due to central BDNF in
the hippocampus is not able to ethically be measured. The line of research continues to

be active due to all the positive influences BDNF is said to have, in addition to appetite

control, regulation of heart rate, and increase insulin sensitivity, on the human brain

across all ages and genders (Marosi & Mattson, 2014).
Purpose of the Study
The purpose of this study was to examine the impact of gender on acute aerobic
exercise induced BDNF and cognitive function among older individuals.
Hypothesis

The hypothesis of the current study was that acute aerobic exercise would

increase BDNF levels and enhance cognitive processing time post exercise followed by
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a drop in BDNF and a return of cognitive processing time to baseline post-30 minutes. It

was also hypothesized that women would have higher BDNF values compared to men.

As for during the control trial, it was hypothesized that the BDNF levels and cognitive
processing time would remain constant at each time point of measurement for both
genders.
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CHAPTER II

LITERATURE REVIEW

Brain Derived Neurotrophic Factor (BDNF)
BDNF is a neurotrophin that is expressed within the central and peripheral

nervous system, specifically within the hippocampus, cerebral cortex, and amygdala

(Begliuomini et al., 2007). BDNF is a protein that is crucial to the development,
maintenance, and plasticity of the central and peripheral nervous systems and plays a key

role in learning, memory, and behavior. BDNF provides support to different

subpopulations of neurons in both a neurotrophic and neuroprotective manner during
their development across the lifespan (Adlard et al., 2004). BDNF is neurotrophic when
there are low circulating levels causing neuropsychiatric disorders like that of depression,

bipolar disorder, schizophrenia, and neurodegenerative diseases such of that as

Alzheimer’s disease and Parkinson’s disease (Begliuomini et al., 2007). BDNF is also
neuroprotective in higher amounts within the brain, which can be boosted prominently by
physical activity as well as proper nutrition, sunlight, and living a healthy lifestyle

(Begliuomini et al., 2007).
BDNF is existent in large quantities within blood platelets, despite the name
“brain-derived,” and is also synthesized within the human body’s epithelial and vascular
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cells, muscle cells, macrophages, and leucocytes (Boudewijn et al., 2011). Research is

not clear about bidirectional transit of BDNF across the blood-brain barrier. Regardless,

plasma levels of BDNF have been shown to be similar to brain levels. This is supported
by recent studies revealing that abnormal levels of BDNF are associated with several
mental disorders and appears to be a biochemical marker of such mental disorders

(Boudewijn et al., 2011). This has led researchers to utilize plasma BDNF as a
biochemical marker for Parkinson’s disease and Alzheimer disease. However, the BDNF
biochemical markers in patients with neurodegenerative diseases can be due to limited

medications effects (Boudewijn et al., 2011).
BDNF initially is synthesized as a precursor protein called pre-proBDNF within
the cell’s endoplasmic reticulum that is eventually transformed into proBDNF and further
processed into mature mBDNF (Marosi et al., 2014). ProBDNF as well is released by
neurons, which is altered by the tissue plasminogen activator (tPA) plasmin system to

mBDNF (Marosi et al., 2014). The expression and distribution of BDNF is stimulated by
excitatory synaptic activity and specific neuropeptides and hormones (Marosi et al.,

2014). Glutamate released from the exact same excitatory synapses binds to the receptors
on the synaptic membrane, causing an influx of Na+ and Ca2+ through various receptors.

Ca2+ activates Ca2+-calmodulin-dependent protein kinase (CaMK), protein kinase C
(PKC), and mitogen-activated protein kinases (MAPKs) which in result activates the
transcription factors cAMP response element-binding protein (CREB) and nuclear factor

kB (NF-kB) to prompt BDNF gene transcription (Marosi et al., 2014). BDNF is
specifically concentrated in vesicles that are transported into axons, presynaptic

terminals, and dendrites from which it is released in response to the glutamate receptor
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activation (Marosi et al., 2014). As well derived from dendrites is that of BDNF mRNA,
the protein translation can be stimulated by synaptic activity. Local BNDF production

and release activates its high-affinity receptor tropomyosin-related kinase B (TrkB) or the
low-affinity p75 neurotrophin receptor on synaptic partner neurons and other cells in its

immediate vicinity. TRkB is a receptor tyrosine kinase that when activated engages with

a number of receptors leading to activation of transcription factors that regulate
expression of proteins involved in neural plasticity, stress resistance, neurotransmitter and
neuropeptide production and excitability, and cell survival (Bathina and Sas, 2014;

Begliuomini et al., 2007; Marosi et al., 2014).

Estrogen, Androgen, and BDNF
Both genders produce and release BNDF within the brain with levels measured in

blood plasma. However, recent studies have shown that the specific sex hormones
released by males and females impact the amount of BDNF produced. BDNF is present
in the follicular fluid, both in women who are cycling normal and in the women

undergoing ovulation induction for IVF (Seifer, Feng, Shelden, Chen, Dreyfus, 2002;
Seifer, Lambert-Messerlian, Schneyer, 2003). Additionally, BDNF levels in follicular

fluid have been shown to be upregulating by gonadotrophin stimulation, since levels of
BDNF were 27 times higher in follicular fluid of women going through ovulation
induction compared to that of normal cycling women (Seifer et al., 2002). This
information along with much more gave reason enough for research on how hormones

affect humans BDNF levels, consequently leading Begliuomini et al. to assess BDNF

plasma concentrations in female subjects specific to their hormonal status.
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Begliuomini et al. (2007) evaluated 60 female subjects for 28 + 2 days to allow
the fertile women to go through a full menstrual cycle (Begliuomini et al., 2007). The
women were split into three groups, 20 fertile women aged 20-40 years with a BMI

between 20-23; 15 amenorrhoeic women, for a minimum of six months, aged 21-42 years

with a BMI of 18.5-24; and 25 postmenopausal women aged 48-70 years with a BMI of
21-25 (Begliuomini et al., 2007). Overnight fasting took place and a blood draw from the
cubital vein from each subject took place between 7:00 am and 9:30 am to avoid possible

circadian variation of blood plasma BDNF concentrations. Five of the 20 ovulatory
women were tested every two days, in other normal menstruating women blood was

drawn during the follicular phase (days 6-8) and luteal phase (days 20-24), amenorrhoeic
women had blood draw every ten days for a total of three times, and after the initial blood

drawn ten of the postmenopausal women started on HRT of estradiol valerate and
underwent blood draws after six months of treatment (Begliuomini et al., 2007). Blood

plasma levels of BDNF were determined with the ELISA method after appropriate
dilutions of samples. It was found that fertile women show significantly higher plasma
BDNF levels during the luteal phase compared to that of the follicular phase, almost three

times as much (Begliuomini et al., 2007). BDNF levels were lowest in the early
follicular phase (Days 1-8: from 292.9 pg/mL + 77.4 pg/mL on Day 2 to 541.8 pg/mL +

113.7 pg/mL on Day 8), then increased significantly from Day 10 of the menstrual cycle,

and then reached a peak value on Day 14; after ovulation (Days 16-18), BDNF levels

decreased and increased again in the mid-luteal phase (Days 20-24), reaching a second
peak on Day 24 (1186.4 pg/mL + 190.6 pg/mL); finally a marked fall in BDNF at the end

of the cycle on Day 28 expressed values similar to that seen in the early follicular phase
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(Begliuomini et al., 2007). Amenorrhoeic women showed the lowest BDNF plasma
levels (150.7 pg/mL + 80.7 pg/mL) in comparison to the rest of the subjects (Begliuomini

et al., 2007). Lastly, BDNF plasma levels of postmenopausal women were lower in
comparison to follicular phase levels of menstruating women (280.6 pg/mL + 116
pg/mL) (Begliuomini et al., 2007). For women who took part in six months of HRT for

menopause, BDNF plasma levels returned to that of almost the same as fertile women in
the follicular phase. There is also an age-related decrease of BDNF in women, with aged
women showing the lowest concentrations (Begliuomini et al., 2007). Concluding, that

there is an influence of hormonal status on that of plasma BDNF. Begliuomini et al.

(2007) suggest that modifications in BDNF circulating levels during menstruation
suggest a potential role by gonadal sex hormones and progesterone in the expression of
the nuerotrophin.

When compared with estrogen, fewer studies have been conducted on men and

how androgen has an effect on BDNF expression. However, it is suggested that men
have the same age-related decline as that of women (Boudewijn et al., 2011). It is

reported that females and males do not have a significant difference in the amount of
hippocampal BDNF, conversely females do tend to have more BDNF within the
prefrontal cortex though (Wei, Y., Wang, S., & Xu, X., 2016). As well, several studies

have reported that testosterone, a major component of androgens, is a positive regulator

of BDNF expression or reproduction (Carbone et al., 2012), concluding that there is a
link between BDNF and sex hormones. However, this link and its potency are further

determined by the specific physiological and pathological characteristics of the human,
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like that of his or her body weight and composition, hormonal status, and enzyme

activities (Carbone et al., 2012).
Those pathological characteristics like body weight and hormonal status in

addition to age and gender and how they related to BDNF production are further
discussed by Lommatzsch et al. (2005). Lommatszch et al. (2005) examined 140 healthy

(72 men, 68 women), adults aging 20-60 years old to discover the impact of age and
physical parameters on BDNF levels in human platelets and plasma. Blood was taken
between 7 and 10 am to minimize the effects of a possible circadian rhythm of BDNF

concentrations (Lommatszch et al., 2005). Total and differential blood cell counts were
analyzed by standard hematological procedures and a dedicated analyzer and BDNF and

TGF-B1 levels in both serum and plasma were analyzed via ELISA, in addition
serotonin, immunoglobulin E (IgE), triglycerides and cholesterol were all measured.
Results found that there was a negative correlation between plasma BDNF levels and age.

When the data was divided into three groups according to age, those being group A: 20

33 years old, group B: 34-47 years old, and group C: 48-60 years old, there was no
significant difference in weight, height or gender between the groups (Lommatszch et al.,

2005). With age, it was found that there were decreasing variance of plasma BDNF
levels over time. There was a negative correlation between plasma BDNF levels and

body weight and there was no significant correlation between weight and platelet BDNF.
When evaluating both genders, women had significantly higher BDNF levels in plasma

then men. However, women had significantly lower body weight than men (69.3 ± 15.6
kg versus 84.8 ± 11.5 kg respectively) (Lommatszch et al., 2005). When men and
women were grouped together based on weight there was no significance in BDNF
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plasma levels between women and men. In regards to menstruation, there was no

difference between women in the first half of the menstrual cycle and women in the
second half of the menstrual cycle (105.5 pg/mL versus 159.3 pg/mL respectively), while
there was a significant difference in women that were postmenopausal (60.8 pg/mL)

which researchers attributed to greater age and weight (36.0 years versus 37.0 years
versus 51.5 years; 68.0 kg versus 61.0 kg versus 69.5 kg respectively)(Lommatszch et al.,

2005). To conclude, the data discovered suggests that parameters such as age, weight or
gender have specific impacts on stored platelets and circulating plasma levels of BDNF
in healthy adults (Lommatszch et al., 2005).

Aging and BDNF

It is well known that with aging there is a decline in cognition function
(Rasmussen et al., 2006). However, this decline is not all due to aging. There are other
associated factors that may speed up the rate of decline including poor quality of life,

decreased social function, and hospitalization (Rassmussen et al., 2006). The
hippocampus of the brain is strongly associated with cognitive function, and with it being
an important area of the brain the hippocampal volume shrinkage is of concern for those

in late adulthood. Specifically, research of what neuromuscular factors trigger the decay
in aging humans is attractive due to delaying these factors.

Erickson et al. (2010) performed a cross-sectional study utilizing MRI, enzyme-

linked immunosorbent assays (ELISAs), and measures of spatial memory to assess age

related decreases in brain volume, plasma BDNF, and memory in older adults. A total of
142 participants between 59 and 81 years of age (mean: 66.5 years, 76% female) were

studied upon passing screening for dementia and met criteria for participating in MRI
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(Erickson et al., 2010). Erickson utilized MRI in order to look at intracranial volume,
looking specifically at the sum of gray, white, and cerebrospinal fluid to compare later to
cognition in relation to BDNF levels (Erickson et al., 2010). To test whether BDNF and
hippocampal volume would be related to age-related changes in the function of memory,

all 142 participants completed a spatial learning computerized task one week prior to the
MRI session. The computerized spatial task, performed a total of 40 times, involved

following a set of dots for 500 milliseconds that subsequently disappear for 3 seconds
(Erickson et al., 2010). During this time the subject is asked to remember the location of
the dots, and upon reappearance of the dots they have to acknowledge within 2 seconds if

they are in the same spot or have moved (Erickson et al., 2010). Blood sampling as well

was collected approximately two-weeks prior to the MRI session. Fasted subjects arrived
to the lab to have blood drawn from the antecubital vein and the samples were kept at
room temperature for 15 minutes to allow clotting (Erickson et al., 2010). Serum BDNF

was quantified using the ELISA. Erickson et al. (2010) found that older adults had
significantly lower concentrations of plasma BDNF, small hippocampal volumes, and

poorer performance in accuracy and response time on spatial memory tasks compared to
that of younger subjects. It was also discovered that regardless of age, if the subject had

a smaller hippocampus there was worse memory associated with it, suggesting that levels
of BDNF decline with advancing age is to be true, and that a genetic polymorphism of
BDNF is related to gray matter volume loss in old age (Erickson et al., 2010). Thus,

suggesting that interventions to elevate BDNF might help reduce age-related volume loss
in the hippocampus.
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Exercise and BDNF Expression
There is a large body of literature supporting the relationship between acute
exercise and plasma BDNF (Piepmeier et al., 2015). Research has identified BDNF as

playing an instrumental role in the form and function of the brain and is vital for

cognitive performance in short term adaptations as well as long term via neural plasticity
(Piepmeier et al., 2015). Numerous studies have evaluated acute exercise in relation to

BDNF production and cognitive function, with a variety of different exercise protocols
and modalities studied (Piepmeier et al., 2015).

Since there is a high amount of BDNF

located within the hippocampus of the brain, and this part of the brain is widely accepted
as being fundamental to memory performance, it appears important to assess cognition in

relation to BDNF expression.
Mu, Li, Yao, and Zhou (1999) administered neural injections of BDNF into rats,
which essentially deprived the rats of their natural secretion of BDNF. The rats were
divided into two groups randomly, BDNF antibody-treated (anti-BDNF, n = 7) and

normal sheep immunoglobulin G (IgG) treated control (control, n = 6) (Mu et al., 1999).

An osmotic pump containing either the BDNF antibody or normal sheep IgG was placed

in the neck subcutaneously. The BDNF antibody was created by vaccination of sheep
with recombinant human BDNF (Mu et al., 1999). The rats were placed inside of the

Morris water maze to test spatial learning and memory, wherein the swimming pool

consisted of a circular tank of 130 cm in diameter and 50 cm in height with an escape
platform placed 1 cm beneath the water’s surface and 32 cm from the pool’s wall (Mu et
al., 2012). The surface of the water was covered with 1 cm diameter Styrofoam beads to

eliminate view of the escape platform. The rats went through one week of
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intraventricular infusion of either the antibody BDNF or control IgG and were subjected

to four consecutive trials per block, with two blocks per day for a total of 4.5 days was
performed (Mu et al., 2012). The rats were placed in the pool in 4 different locations to

find the escape platform in 120 seconds, if not found the trial was terminated and an
escape latency was recorded (Mu at al., 2012). The rats were placed in the pool one last

time on the last day where the platform was removed and they swam for 2 minutes while
the swim distance in each quadrant was calculated for a total distance measurement (Mu

et al., 2012). Results showed that the rodents deprived of BDNF experienced declines in

cognitive performance being they took more time to find the escape platform compared
to that of the controls (74.86 ± 9.80 s, 46.50 ± 4.23 s respectively), thus showing that
BDNF is critical for cognitive performance (Mu et al., 1999). The escape latency in

control rats dramatically reduced in time in the subsequent trials, reaching a plateau of

11.00 ± 2.53 s, while the antibody-treated rats’ average escape latency was much longer
than those in the control group (Mu et al., 2012). The results of swimming speed
between the control and anti-BDNF-treated groups showed no significant difference

(11.9 ± 0.75 cm/s vs 12.1 ± 0.86 cm/s) (Mu et al., 2012). It was concluded that BDNF

plays a role in spatial learning and memory, specifically that of short-term.
Schmolesky, Webb, and Hansen (2013) observed the combined effects of aerobic
exercise intensity and duration on serum BDNF levels in healthy men ages 18-25 years

old. The study was limited to only males due to reducing variability in BDNF levels that
vary across gender and vary with menstrual cycle status in females (Begliuomini et al.,

2007). Subjects self-reported their average weekly exercise patterns the past week, per a
typical week, and over the past six months in specific sports or physical routines
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(Schmolesky et al., 2013). The 45 subjects were then randomly assigned to one of six
exercise conditions based on exercise intensity, those included vigorous, moderate, or
sedentary, and duration, 20 or 40 minutes, using quota sampling (Schmolesky et al.,

2013). The subjects were asked to exercise at the proper duration and intensity assigned
to them. Vigorous activity (80% of HRR) and moderate activity (60% of HRR) were
carried out on the cycle ergometer (Schmolesky et al., 2013). Heart rate was measured

once every minute in order to verify compliance with the program. Antecubital vein
blood draws (5 ml) were performed 5 minutes pre-exercise and 2 minutes post-exercise
for those exercising and the same blood draws at the same timed points were done on the

control subjects who were sedentary watching other subjects exercise for 20 and 40
minutes (Schmolesky et al., 2013). The blood clotted for one hour and then was

centrifuged for 10 minutes and analysis was later done via the ELISA (Schmolesky et al.,

2013). Results showed that under the conditions set, neither factors of intensity or
duration influenced the degree of BDNF increases (pre vs post) that resulted from
exercise (Schmolesky et al., 2013). The average pre-post percentage in serum BDNF
levels was found to be 25-30% in three of the exercise conditions (Vig20 = 26.38 ±

34.89%, Vig40 = 28.48 ± 19.11%, Mod40 = 30.16 ± 72.11%) and was higher
numerically in the fourth condition (Mod20 = 41.23 ± 59.65%) (Schmolesky et al., 2013).

Interestingly, the average sum percentage of serum BDNF decreased in both control
conditions (Con20 = -14.48 ± 16.50, Con40 = -10.51 ± 26.78) while there was no

significant differences between the average sum percentage of serum BDNF values in the
two control groups (t(8) = 0.173)(Schmolesky et al., 2013). Concluding, that under the
conditions set that neither factors of intensity nor duration influenced the degree of
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BDNF increase that resulted from exercise (Schmolesky et al., 2013). However, these

factors did more than likely play a role in both the probability of a subject achieving a
significant BDNF increase and in the volume of circulating BDNF being produced
(Schmolesky et al., 2013).

Similar to that of Mu, a study put forward by Adlard (2004) examined the
timecourse of induction of BDNF mRNA and protein after 1, 3, 5, 7 ,14 and 28 days of
exercise in male rats. Female rats were not used in order to avoid the perplexing effect of
cycling hormones. The rats were individually housed in cages with access to food and

water ad libitum in a 12-hour dark and 12-hour light varium (Adlard et al., 2004). A

subset of rats were set up in cages with a running wheel for either 1, 3, 5, 7, 14, or 28
days (n = 6 rats at each time point) (Adlard et al., 2004). Observation of the number of

wheel revolutions was recorded continuously via a computer software attached to each
running wheel. Sedentary control rats (n = 12) had been housed for the same amount of

time in the same cages as the active wheel running rats. Another subset of rats performed
water maze exercise (n = 7 per group), they were exercised 3 weeks prior to and during
testing (Adlard et al., 2004). Another sedentary group was tested concurrently (n = 8 per

group). The protocol for these rats consisted of two trials per day for six consecutive
days, an overhead CCD camera attached to a VCR videotaped all activity. BDNF, in

addition to mRNA, was found via micro-dissection of the rats’ hemispheres of their

brains (Adlard et al., 2004). Results found that the induction of BDNF over the
timecourse showed an overall main effect (Adlard et al., 2004). The group of rats given
28 days on the running wheel had a significant upregulation in BDNF compared to that of
the sedentary group (271% increase), and this same 28-day rat group had significantly
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higher BDNF levels compared to all other timepoints (trend seen at 14 days = 166%

compared to sedentary) (Adlard et al., 2004). The exercised rats involved in the water
maze trials showed a decreased escape latency compared to that of sedentary rats, there

was a significant difference shown after 2 days and from day to day (Adlard et al., 2004).
In conclusion, showing that exercise training modulates the induction of BDNF mRNA

and protein in a time-depending manner within the hippocampus of the brain at a peak of
28 days, it is suggested that this may contribute to the maintenance of brain health and

plasticity (Adlard et al., 2004).
Exercise, Cognition and BDNF
Like that of studies looking specifically at the effects of exercise on BDNF, there
are numerous studies that have looked at these two factors and the effects they both have

on cognition. The reason researchers believe there is a trend connecting BDNF to
improved cognition is that BDNF is thought to play a key role in the health of the central

nervous system impacting neuronal survival, growth, and maintenance (Cotman &

Engesser-Cesar, 2002), and has been proven to have an interaction in the consolidation in
nonhuman animal studies (Mu et al., 1999) and in human studies (Egan et al., 2003) after

as little as just one bout of exercise.

Etnier et al. (2016) performed a study to extend previous research and explore

dose-response relationships between exercise intensity and memory by testing
associations with exercise-induced changes in BDNF. Sixteen young (M = 23.06 years)
adult men (n = 9) and women (n = 7) had their learning, episodic memory, short-term
memory, and long-term memory assessed via the Rey Auditory Learning Test
(RAVLT)(Etnier et al., 2016). Participants were read a primary word list (List A)
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consisting of 15 words and were asked to recall as many words as possible in no
particular order indicating their short-term memory capability (Etnier et al., 2016). List

A was repeated another four times and the participants were asked to recall the words
following each trial, the change in performance across those five trials was indicative of
their learning (Etnier et al., 2016). After the fifth trial, participants heard a new list of 15

words (List B) and were asked to recall those words (Etnier et al., 2016). Then, without
hearing the list again, the participants were asked to recall as many words as they could
from List A. Participants were then asked to again recall as many words as possible from

List A 30-min later (Etnier et al., 2016). Then the next day participants were contacted

via phone to complete a 24-hour recall test where a combination of List A, List B, and 20

distracting words were said and the participants had to identify which group the words
belonged providing additional measures of long-term memory (Etnier et al., 2016). Prior

to the RAVLT trials 1-7 testing, participants performed a VO2 max test for session 1 and
submaximally exercised for 30 minutes on a treadmill for sessions 2 and 3. Blood
samples were taken pre-exercise, post-exercise, and post-memory test to assess BDNF

and estradiol in women. BDNF data expressed there was a significant effect for time
while exercise intensity and exercise intensity x Time were not significant (Etnier et al.,

2016). BDNF serum increased significantly from baseline (M = 15,438.3 ± 1,577.1
pg/mL) to post-exercise (M = 21,502.93, SE = 2,117.42) and then decreased significantly
by 30-minutes post-exercise (M = 17,010.20, SE = 1,074.24) (Etnier et al., 2016).
Results for short-term memory and long-term memory indicated that there was not a

significant difference due to exercise intensity, however there was a nearly significant

difference in performance as function of exercise intensity and a significant difference as
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function of trials (Etnier et al., 2016). Performance on the memory task increased
significantly from Trial 1 (M = 6.74, SE = 0.29) to Trial 2 ( M = 9.36, SE = 0.41) and

then plateaued expressing no significant difference from Trial 3 to Trial 4 (M = 11.83, SE
= 0.28) and Trial 4 from Trial 5 (M = 12.48, SE = 0.38)(Etnier et al., 2016). The overall
interaction of exercise intensity x Trial was not significant. Concluding, results of this

study support that there is a threshold effect of exercise intensity, higher intensity
exercise resulting in significantly better effects than lower intensity exercise, on learning

and long-term memory (Etnier et al., 2016).
Similarly, Damirchi, Hosseini, and Babaei (2017) were also interested in how
exercise affects BDNF and cognition, and these researchers even looked to see if mental
training had an effect as well. The goal of this study was to evaluate the effect of the

combination of physical and mental training on cognitive performance, serum BDNF,

and irisin level in patients with mild cognitive impairment (MCI)(Damirchi et al., 2017).
Of the 101 elderly women who volunteered from Yas adult center, a nonresidential

female adult daycare center in Aliabad-e Katul, Golestan Province, Iran, 54 sedentary
women were randomized into four groups: physical training (PH; n = 15), mental training

(ME; n = 15), PH + ME (n = 15), and control group (CO; n = 9)(Damirchi et al., 2017).
Of those 54 elderly women, 44 completed the protocol accurately over the 8-week study.

Four cognitive assessments were performed: working memory, processing speed,
reaction time, and error number of the computer modified Stroop color-word test. All

cognitive measurements were carried out two days prior to and post intervention and 6
months after the last training for testing the maintenance of behavior. Serum BDNF and
irisin were measured before and after the ending experiments, a total of two times. Those
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participants in the mental training group started exercising with a special program entitled

“Modified My Better Mind” partaking in games that worked on visual attention, visual
and verbal memory, speed of processing, reasoning and more under the supervision of a

physiotherapist for 30 minutes weeks 1 through 6 and for 60 minutes in weeks 7 and 8

(Damirchi et al., 2017). The physical training was 3 days per week and consisted of two
sections: 5-minute warm-up followed by 6-minute walking with 55% of heart rate reserve
and slowly reaching up 20 minutes with 75% of heart rate reserve by the eighth week;
and muscular strength, range of movement (MSROM) Silver Sneakers who partook in
group fitness following a similar 5-minute stretching protocol, muscular range of motion
exercises coupled with light cardio for 25 minutes total (Damirchi et al., 2017). Those

participants within the combined training group participated in both physical and mental

training, performing the cognitive training prior to the exercise training (Damirchi et al.,
2017). What was discovered was that there was a significant increase in working
memory from pretest to post-training in ME and PH + ME (Damirchi et al., 2017).

Changes in working memory were significantly higher in ME (21.64%) compared with
PH (-0.20%) and CO (-1.16%)(Damirchi et al., 2017). Likewise, there were significant

improvements in the post-training scores of processing speed and reaction time in only
the ME group when compared with pretest values (Damirchi et al., 2017). Changes in
processing speeds were significantly higher in ME (10.24%) compared to PH (-0.42%)

and CO (-0.65%)(Damirchi et al., 2017). While improvements in working memory,
processing speed, reaction time, and error number were preserved after 6 months of

detraining in ME and working memory, the only improved index for PH + ME, decreased
significantly after 6 months of detraining (Damirchi et al., 2017). All while BDNF
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increased significantly in ME and PH + ME and reduced in PH (Damirchi et al., 2017).

Being the physical activity group showed no significant change in cognitive function,

BDNF, or irisin researchers attributed this to intensity of exercise which was lower than
the intensities used in studies that had positive results. The group that combined physical

activity and mental training showed significant changes in working memory and BDNF
while the mental training group had improvements in cognitive performance that

remained stable for 6 months. In conclusion, the mental training has beneficial effects in
older adults and is a useful and safe strategy to prevent cognitive decline via BDNF
elevation (Damirchi et al., 2017).
Heisz, Clark, Bonin, Paolucci, Michalski, Becker, and Fahnestock (2017) came

together with a similar purpose like that of Damirchi et al. to examine the combined
effects of exercise and cognitive training on memory and neurotrophic factors. However
rather than utilizing elderly women, young adults were used. Being that exercise-induced

brain plasticity may be dependent on the individual’s fitness improvements from exercise

training, it was hypothesized that individuals with greater fitness gains from exercise
training would show greater increases in high-interferences memory and neurotrophic

factors in comparison to individuals with lower fitness gains (Heisz et al., 2017). Ninetyfive healthy young adults (58 women, 37 men, age = 21 ± 3 years, range = 17-30 years)

partook in the present study and were assigned to three groups: control (n = 7), exercise
training (n = 3), and combination exercise and cognitive training (n = 6) (Heisz et al.,

2017). Exercise training consisted of 20-minutes of high intensity interval training (HIT)
for a total of 6 weeks, 3 times a week (Heisz et al., 2017). Individualized exercise
prescriptions based off of preliminary VO2 max testing were utilized, participants
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completed the HIT on stationary cycle ergometers. Combined exercise and cognitive
training consisted of the same exercise training plus cognitive training completed on the

same day at the same session. Cognitive training consisted of 20 minutes of training on a
computerized version of the Concentration Memory Task for a total of 6 weeks, 3 days
per week (Heisz et al., 2017). Participants began training at level 1 and that was

increased periodically through training and were presented with different numbers of

cards each session to remember, cognition training was done prior to exercise training

(Heisz et al., 2017). The control participants did not perform either training protocols
and were asked to remain sedentary for the whole 6 weeks. The experimental procedure
included pre- and post-testing that was done over the span of two days: day 1 started with

a 12-hour fasted blood draw, followed be a meal, and then cognitive testing and day 2 the
participants completed aerobic fitness training, then pre- and post-testing sessions were
separated into the 6-week intervention groups and post-testing was done within 48 hours
after intervention completion (Heisz et al., 2017). Kirwan and Stark’s mnemonic

similarity task was utilized to assess memory function pre- and post-intervention (Heisz

et al., 2017). Results showed that for high-interference memory task that there was a
main effort of group, high-interference memory improved more for the exercise and the

combined training groups than the control group. There were no group differences
observed for BDNF levels or recognition memory scores. For recognition memory, a t-

test revealed that untransformed pretest (95% CI (-18%, -13%) and posttest (95% CI (
18%, -14%) recognition scores were significantly lower than 100%, suggesting that the
effect of group on recognition memory was not due to a ceiling effect (Heisz et al., 2017).

Concluding that exercise training selectively enhanced performance on an untrained high-
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interference memory task, serum BDNF and IGF-1 levels increased significantly in

individuals who exhibited larger aerobic adaptation to exercise training suggesting that
due to training level there are differences (Heisz et al., 2017). As well, those high

responders to exercise who received cognitive training in addition to exercise training had

better high-interference memory than those who exercised only. This suggests that the
potential for synergistic effects of combination training may depend on the level of a

person’s training.

Kim, Lee, Lee, Cho, and Ko (2018) meets Damirchi et al. and Heisz et al. in the

middle, and performed a study to evaluate the effects of a cognitive enhancement fitness
program (CEFP) on short-term memory and serum BDNF levels according to cognition

status in not young, not old, but middle aged women. A total of 30 healthy volunteers
that are between the ages of 40-59 years old were divided into two groups: mild cognitive
impairment (MCI) and non-MCI. To discover which group these women belonged,

volunteers were screened based on the Korean Dementia Screening Questionnaire. A

single session of CEFP was performed by each subject and lasted 50 minutes in duration,

it consisted of four parts: warm-up, low intensity interval circulation dance exercises,
moderate intensity resistance exercises, and a cool-down (Kim et al., 2018). Dance
exercises consisted of bounce, side-to-side, twist, swan lake, lady’s kick, jump, swerve

and shuffle dances and the resistance exercise consisted of bicep curls, chest press, single

arm press, lateral raise, overhead pull, good mornings, squat, kicks (Kim et al., 2018).
Serum BDNF was taken one hour prior and post-exercise program and were evaluated
via ELISA while short-term memory was determined by forward digit/word span test pre

and post exercise (Kim et al., 2018). The test consisted of the examinee reading a
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sequence of digits, then recalling the digits in the same forward sequence starting at level

1 and attempting all the way till level 10. Results found that after CEFP, forward

digit/word span test scores and BDNF levels increased to 119.2%/115.1% and 118.7%
respectively (Kim et al., 2018). After CEFP, the MCI and non-MCI groups produced

higher forward digit span test scores (from 6.7 ± 1.5 to 7.5 ± 1.4 points and from 6.2 ±

2.0 to 7.0 ± 2.1 points respectively)(Kim et al., 2018). After CEFP, forward word span
scores and BDNF levels increased (from 3.5 ± 1.7 to 4.6 ± 1.8 points and from 610.8 ±

221.1 to 757.9 ± 267.9 pg/mL respectively)(Kim et al., 2018). In conclusion, after 50minutes of CEFP short-term memory and BDNF levels improved in healthy middle-aged
women, especially those without MCI (Kim et al., 2018). As well, that short-term

memory and BDNF levels after CEFP were found to be negatively correlated with age,

but pre- to post-intervention changes in short-term memory and BDNF were not (Kim et

al., 2018).
Wiet (2018) as well looked at the effects of exercised induced BDNF levels and
cognition, but in premenopausal and postmenopausal women. Assessment of 14 active

females, seven premenopausal and seven postmenopausal, was conducted over two

different trials, one being an exercise trial and the other a controlled reading trial (Wiet,

2018). The exercise trial consisted of running on a treadmill at 75% of their VO2 max for

a total of 30 minutes while the control trial consisted of a light reading session for the
same amount of time. A blood sample to look at plasma BDNF levels and the Stroop test
to assess cognition and reaction time was administered before, immediately after, and 30
minutes post-exercise, as well as for the control trial. Results showed that there was an
interaction between the two groups in BDNF levels over time. It was discovered that
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premenopausal women had a rise in BDNF levels after exercise and postmenopausal
women had a decrease in BDNF levels after exercise (Wiet, 2018). Additionally, a

correlation was found between age and cognitive performance over each time point,
indicating that the postmenopausal group was significantly slower in pre-testing and post30 minute-testing in both the exercise trial and control trials. This provides evidence for

a decline in incongruent choice reaction time because of one’s age (Wiet, 2018).
Another study looked into the effect of an acute aerobic exercise session,
resistance exercise session, and aerobic resistance exercise session on cognition and

BDNF. Paul (2016) observed ten healthy, physically active subjects capable of at least
30 minutes of vigorous activity, five of them males and five females. The Stroop test was

used for cognitive assessment where the subject had to name the color of the ink rather

than the word, and a lower score was considered a better score (Paul, 2016). A 5 ml

blood sample was taken via the antecubital vein at rest, immediately post-exercise, and
30-minutes post-exercise (Paul, 2016). The blood samples were stored in an -80°C

freezer until analyzed by a Bio-Tek Synergy plate reader and assessed via ELISA (Paul,

2016). Prior to experimentation body composition was found utilizing the BodPod after
subjects over-night fasted, VO2 maximal testing was done to find the subjects’ maximal

aerobic power, and 1-RM testing for each exercise was performed in order to find the
loads for the resistance workout trial (Paul, 2016). Each exercise condition was
performed during the same time of the day, approximately one week apart. Paul (2016)

found that all modalities elicited a significant rise in BDNF and cognition improvement
(CT (28%) < AT (31%) < RT (45%); CT (~89.5 ms) < AT (~90.5 ms) < RT (~116.4 ms))

immediately after exercise.
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CHAPTER III

METHODS
Research Design
This study was a causal comparative research design to observe gender
differences in acute exercise induced BDNF production and cognitive function among

older individuals. The independent variables were gender, exercise, and time and the
dependent variables were BDNF levels and cognitive function (Stroop Test).

Participants
The study was approved by the Institutional Review Board (IRB) at Cleveland

State University. Of the 23 potential participants who showed interest and came to CSU
to see if they qualified, 18 subjects met the requirements to be eligible for the study. All
eighteen subjects, 9 healthy males and 9 healthy females, were asked to volunteer for the

study. They were recruited as a convenience sample through flyers, social media, and
word-of-mouth. All of the subjects were regularly exercising a minimum of 150 minutes

at moderate intensity or 75 minutes at high intensity five days a week for the past three
months and were between the ages of 60-85 years old. Those females involved in the
study were all postmenopausal. Subjects were required to fast from food and drink, other

than that of water, 10 hours prior to each testing session. All the subjects were asked to
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complete the American Heart Association (AHA) and American College of Sports

Medicine (ACSM) prescreening questionnaire. Only those that were in the low risk
category were chosen for the study, unless a doctor’s note was provided stating they were
cleared to exercise. The TICS-M survey was utilized to assess for early cognitive
impairment and limit those who have signs of cognitive decline from the present study.

The subjects had to pass the TICS-M with a minimum score of 31 out of 46, this
minimum score was determined based off of previous studies. Exclusion criteria

consisted of any muscular skeletal injury, cardiovascular disease, hormone replacement

therapy (HRT) in both men and women, heart rate altering medication, currently

experiencing menopause, recent smoking history, metabolic or endocrine disease,
neurological disabilities, color blindness, a percent body fat of > 35% for women and
> 23% for men, and the inability to bike for 30 minutes at a moderately high intensity.

Before the study, each subject was given an informed consent approved by the IRB.
Body Composition and Anthropometry
Height and body composition were measured upon arrival to the Human

Performance Laboratory. Height was measured via a clinically calibrated stadiometer,

weight was measured, and body composition and weight were determined using air
displacement plethysmography via the BodPod system (Life Measurement Instruments;

Concord, California).

Blood Sampling
Serum BDNF, testosterone, and estradiol levels were determined within this

study. Blood samples were taken immediately before, immediately after, and 30 minutes
after exercise and the control trial. Ten mL of venous blood was drawn with the aseptic
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technique from the antecubital vein at each time portion, with a total of 30 mL of blood

drawn per session and 60 mL for study total. Only phlebotomy-trained individuals drew
blood from the subjects using sterile technique. All supplies used for blood sampling
were discarded in accordance with biohazard regulations. Blood was collected in 5 mL

serum-separating tubes, with samples allowed to clot for a minimum of 30 minutes at
room temperature. The samples were spun in the centrifuge, and the serum was collected

and stored in a -80 degrees Celsius freezer until analyzed. BDNF, testosterone, and

estradiol levels were measured with commercially available ELISA kits using a Bio-Tek
Synergy plate reader.
Cognitive Test

The Stroop Test is a widely used, reliable, and valid test designed to test cognitive
performance specifically by testing the subject’s selective attention capacity and skills, as
well as reaction time. The incongruent style was administered being it is the most

relevant test for measuring executive function. The Stroop word-color test consisted of
three different trials for both exercise and control (pre, post, and thirty minutes post) via a

computer program. The incongruent style of Stroop Test was used which consisted of
four different colors: red, blue, green, and black. The subject was asked to name the

color of the text rather than the spelling of the word. The subjects were asked to
complete the test as quickly and efficiently as possible.

Experimental Protocol

The 18 subjects were assigned for which trial they would complete first based on
when they signed up for the study. The participants with an ID number that was odd

would exercise first and the participants with an ID number that was even would exercise
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on the second visit. Subjects reported to the Human Performance Lab at Cleveland State

University on two different occasions and completed those visits as follows:
1st visit

1st visit upon qualification

2nd visit

1. Signed consent form

1. Practiced Stroop Test

*opposite trial of 1st visit

2. AHA/ACSM

2. Pre-exercise or control

1. Practiced Stroop Test

questionnaire was

completed
3. Blood pressure, heart

rate, height and weight

were taken
4. TICS-M was performed

5. Body fat assessed via
the BodPod

6. Stroop Test was
explained
7. Blood draws were

explained

blood draw

3. Pre-exercise or control

Stroop Test
4. Exercise or control for
30 minutes
5. Post-exercise or control

blood draw

6. Post-exercise or control

Stroop Test
7. Subjects rested for 30

2. Pre-exercise or control

blood draw

3. Pre-exercise or control
Stroop Test
4. Exercise or control for

30 minutes

5. Post-exercise or control

blood draw

6. Post-exercise or control
Stroop Test

7. Subjects rested for 30

minutes

8. Post-30 minutes exercise

minutes

or control blood draw

8. Post-30 minutes exercise

9. Post-30 minutes exercise

or control blood draw

or control Stroop Test

9. Post-30 minutes exercise
or control Stroop Test
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Exercise Protocol
The subjects performed a 30-minute bout of aerobic exercise on either a stationary
or recumbent bike of their choice. Subjects were given a five-minute warm up at a speed
that allows the subject to reach 75% of their age-predicted maximal heart rate.

Percentage of HRmax was used rather than performing a VO2 max test and using that to
find intensity being 75% of HRmax corresponds to ~60% of VO2 max. Once this speed

was detected, it was initiated for 30 minutes of exercise and altered if their heart rate was
too high or too low. After the 30 minutes of exercise, subjects were allowed to cool
down and then asked to stop and to rest for the subsequent 30 minutes. Heart rate and

rate of perceived exertion were measured throughout the exercise test. Blood draws and
Stroop Tests were both initiated prior to exercise, immediately after exercise, and 30
minutes after exercise.

Control Protocol
Subjects in addition to exercise performed a control trial where they read the
book, Endure by Alex Hutchinson, for 30 minutes in a controlled room with no
interruption. After the 30 minutes of controlled reading, subjects were asked to rest for

the subsequent 30 minutes like that of the exercise trial. Blood draws and Stroop Tests
were both initiated prior to control, immediately after control, and 30 minutes after

control.

Statistical Analysis
Descriptive statistics were obtained. Repeated measures ANOVAs were
conducted to observe changes in BDNF levels and cognitive performance over time and
between the two groups. Post hoc pairwise comparison was used to explore any observed
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main and interaction effects. Kendall’s Tou Correlations were used to assess the
relationships between BDNF, cognition, age, gender and hormone status. A One-Way
ANOVA was done in order to observe any statistical differences between estrogen and

testosterone levels between the two groups. SPSS (version 26) was used for all analyses

with .05 used as the level of significance.
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CHAPTER IV

RESULTS AND DISCUSSION

A repeated measures ANOVA was done in order to observe any changes in
cognition due to exercise. There was a significant difference in Stroop times during all

time points (pre, post, post30) in both exercise and control trials (F = 9.343; p = 0.001)
across all subjects. There was no significant difference between exercise or control
conditions and no impact due to gender. Pairwise comparisons were also done and

showed a trend (p = 0.068) for a decrease in Stroop time from the pre to immediate-post
timepoints, and a significant decrease (p = 0.004) in Stroop time from the pre to post-30

timepoints. There was no significant evidence found, but it was observed that men had
slower Stroop times than women throughout each time point for exercise and control

(exercise: 1,379.5, 1,322.1, 1,330.6 versus 1,261.7, 1,193.6, 1,167.1; control: 1,484.6,
1,394.6, 1,304.7 versus 1,425.3, 1,311.8, 1,239.8 respectively). There was no significant
evidence found to support the finding, however it was observed that overall Stroop times
in the control trials were slower than the exercise trials. The results of the study are

shown in the following tables and figures.
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Table 1. Subject Characteristics, Mean ± Standard Deviation

Measure

All

Males

Females

N

18

9

9

Age (yrs)

67.4 ± 5.8

69.6 ± 6

65.3 ± 5

Height (in)

66.5 ± 3.3

68.3 ± 3.1

64.6 ± 2.3

Weight (lbs)

140 ± 18.3

149.5 ± 16.1

130.6 ± 15.7

Body Fat (%)

19.4 ± 9.5

12 ± 6.3

26.7 ± 5.6

75% of HRmax (bpm)

120.6 ± 3.2

119.6 ± 3.3

121.7 ± 2.9

Measured
Exercise HR (bpm)

130.6 ± 7.7

127.1 ± 8.1

135.5 ± 6

Estrogen (pg/mL)

74.2 ± 42.3

87.3 ± 51

61.2 ± 32.5

Testosterone (ng/dL)

4.4 ± 4.1

6.8 ± 4.1

1.2 ± 0.6*

*one woman’s testosterone results were not included in the averaged results due to
being an outlier (greater than two standard deviations above the mean).
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Cognitive Assessment

Exercise versus Control Average
Stroop Test Time

Exercise

Control

Figure 1. The incongruent Stroop Test results from both exercise and control trials (pre,
post, and post30).
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Figure 2. The effects of acute aerobic (75% of MHR) and control on BDNF levels
(1 -pre, 2 - post, 3 - post30). * = (p < 0.5) Exercise trial (1 - blue) versus control trial (2 red)
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Averaged BDNF Levels of Females and Males Across All
Timepoints in Control and Exercise

Figure 3. Average BDNF levels across all timepoints (pre, post, post30) for exercise and

control trials for both groups (males; females).
A repeated measures ANOVA was done in order to observe any changes in
BDNF levels due to exercise. Seen in figure 2, there was a significant interaction
between BDNF levels over time due to exercise (F = 3.268; p = 0.05). A Post Hoc test

was done to further investigate this interaction. There was a non-significant drop in
BDNF from post to post-30 exercise whereas there was no change in control BDNF from

post to post-30. An independent samples t-test was also conducted and expressed that
females had significantly higher BDNF than males across all timepoints and conditions

(females = 32,239.9 ± 2,446.4 pg/mL; males = 25,074.1 ± 2,446.4 pg/mL; p = 0.055).
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Correlations with Age
A Pearson Correlations analysis showed significant, positive correlation between
age and pre-exercise Stroop time (p = 0.004, r = 0.640), post exercise Stroop time (p =
0.002, r = 0.676), and post 30 exercise Stroop time (p = 0.006, r = 0.624).

Age

Figure 5. Age versus Stroop time pre-exercise
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Age

Post30Ex

Figure 6. Age versus Stroop time post exercise

Age

Figure 7. Age versus Stroop time post-30 exercise
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Hormone Levels and Body Composition
An independent samples t-tests was conducted and expressed that males had
significantly higher testosterone than females (p = 0.007), and significantly lower body

fat (p < 0.001). However, there is no significant relationship between hormones and
BDNF.

Discussion
It was discovered that there was a significant difference in cognitive processing
time via the Stroop Test at all time points (pre, post, post30) in both exercise and control
trials (p = 0.001) across all subjects. Additionally, there was a trend (p = 0.068) for a

decrease in Stroop time from the pre to immediate-post timepoints, and a significant
decrease (p = 0.004) in Stroop time from the pre to post-30 timepoints. Some research,
like that of Wiet (2018) who tested premenopausal women and postmenopausal women

and Paul (2016) who tested subjects based on mode of exercise, found an acute
improvement in Stroop Test cognitive processing time post-exercise which then returns

to baseline 30 minutes after exercise. In the present study it was discovered that with
each time point the cognitive processing time continued to improve in both exercise and

control, which can likely be attributed to a learning effect. Being our subjects are of the

older population, extra familiarization time with the Stroop Test may have been
necessary to avoid this.

Another potential contributing factor to the unexpected Stroop Test reaction
times, may be the role epinephrine plays when the subjects know they are about to
exercise. Ahmadiasl, Alaei and Hänninen (2003) investigated the effects of exercise on

learning and memory, long-term potentiation and levels of epinephrine in treadmill
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trained rats over the span of ten days. They discovered that physical activity produced a
significant enhancement in spatial learning, with decreased path length and latency to the

platform in the Morris water maze with significantly increased levels of epinephrine
(Ahmadiasl et al., 2003). This would make sense as to why for some individuals, but not
all, there was the trend seen of constant improvement in cognitive processing times, and a

faster cognitive processing time in the exercise trials compared to the control trials.
Lastly, another theory of why the elderly population improved over all three

timepoints in the exercise trial for cognitive function may be due to the intensity of the
mode of exercise. Etnier et al. (2016) tested the dose-response effects of exercise
intensity of memory performance and found that there was no significant difference in

short-term memory as a function of condition, meaning the various intensities of exercise
the subjects endured did not differentially influence how many words participants were
able to recall following exposure to the word list initially. This was unexpected by Etnier

et al. (2016) due to their research that found that there should have been a small positive
effect on short-term memory due to acute exercise; however, Etnier et al. never
performed a control group with subjects so they were unable to draw the conclusion from

the results as to whether exercise influenced short-term memory. Etnier et al. (2016) did

although make a suggestion based off of the evidence by Chang, Labban, Gapin, and
Etnier (2012) that there is an association between exercise intensity and cognitive

performance assessed post-exercise based on the timing of cognitive testing. Chang et al.

(2012) states that exercise at lower intensities has been shown to be the most beneficial
for cognitive performance assessed immediately after exercise while exercise at higher

intensities is better for cognitive performances assessed after a delay. With that being
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said, the intensity level of the current study may have not been low enough to benefit

short-term cognition specifically but high enough to benefit long-term cognition as

reaction times continued to improve at each timepoint in our active elderly adults.

It was also found that there was a significant main effect between BDNF levels

over time due to exercise (p = 0.055). The exercise hypothesis was based off of Etnier et
al. (2016) who found that BDNF serum increased significantly from baseline to post

exercise and then decreased significantly by 30-minutes post-exercise in both genders of

young adults. The results of the current study showed a significant interaction when

looking at BDNF based on condition, not considering gender of the elderly adults, where
there was a non-significant drop in BDNF following exercise in the exercise trial while
there was no change in BDNF in the control trial similar to that of Etnier et al. These

results do not support past literature showing that a single bout of exercise increases
peripheral levels of BDNF, which may be due the level of intensity the subjects worked

at when riding either the recumbent or stationary bike. Ferris, Williams, and Shen (2007)
determined there is a relationship between exercise intensity and BDNF responses when

they tested their subjects’ production of BDNF when they performed a graded exercise

test to determine their VO2max and ventilatory threshold on a cycle ergometer, in which
the subjects cycled two subsequent 30-minute endurance rides performed at 20% below
ventilatory threshold and 10% above ventilatory threshold (Ferris et al., 2007). They

discovered that BDNF levels increased from baseline after exercise at 10% above
ventilatory threshold and the graded exercise test, while there were no significant changes

in BDNF from baseline after exercise at 20% below ventilatory threshold (Ferris et al.,

2007). Concluding, that possibly the reason that in the present study the subjects did not
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produce evidence that acute aerobic exercise does induce BDNF production was due to
exercise intensity not being high enough for our active population.

Lastly, it was exposed that females had significantly higher BDNF than males.

These findings are similar to that which was found in Lommatszch et al. (2005) where the

sedentary young females expressed higher levels of BDNF plasma in comparison to that

of the sedentary young males. It has been found that estradiol levels of young fertile
women in comparison to young fertile men were 996-1,377 pg/mL and 10-82 pg/mL

respectively (Begliuomini et al., 2007; Yamamoto, Hibi Katsuno, and Miyake, 1995) and

being that our older males and females had no difference in estrogen, and higher BDNF
levels still persisted in the females within our current study like that of Lommatszch et

al.’s study suggests that there may be an estrogen-independent relationship to BDNF.

Begliuomini et al. (2007) inferred that hormonal status does have an influence on that of

plasma BDNF when he discovered that sedentary postmenopausal women had much
lower plasma BDNF in comparison to that of sedentary women in the mid-luteal phase of

their menstrual cycle, roughly a 1,000 pg/mL difference, in BDNF production. However,

what was discovered in the current study may be a novel finding that suggests looking
into other factors outside of estrogen as the relating cause to elevated BDNF in older

women.
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CHAPTER V

SUMMARY AND CONCLUSION
Conclusion

The purpose of this study was to examine the impact of gender on acute aerobic
exercise induced BDNF and cognitive function among older individuals. It was found

that there was statistical evidence that acute exercise affects BDNF production in both

genders, but not that of cognitive processing time. Additionally, women were found to

have higher overall levels of BDNF. The hypothesis of the current study was that acute
aerobic exercise would increase BDNF levels and enhance cognitive processing time post
exercise and then BDNF and cognitive processing time would return to baseline 30

minutes post exercise in both genders, with women having overall higher BDNF levels

than that of the men. Statistical evidence was not able to show the increase in cognitive
processing time performance post acute aerobic exercise. Rather statistical evidence

showed a decrease in cognitive processing time at post-30 minutes. Therefore, the
exercise and BDNF hypothesis was partially supported that we saw a drop in BDNF after
exercise as compared to the control condition. However, we did not see the exercise-

induced BDNF increase. As for the cognitive processing speed, this was not affected by

exercise. Our hypothesis that females would have higher BDNF than males was
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supported. With that being said, there were observations that support the need for further
investigation in this area of research.

Future Research
Suggestions for future research would be to have a larger sample size. Different

modes of aerobic exercise could reveal different results, an example could be that of

swimming or running contrasting from biking. Increasing or decreasing the intensity of
the aerobic exercise of the study may elicit a different response of BDNF and show

improvements in cognitive performance in either short-term cognition and long-term
cognition respectively. If utilizing the Stroop Test or any other cognitive assessment test
with this population age range, a suggestion to give more time for familiarization with the

test is suggested in hopes that results of reaction time would normalize. It would be
interesting to compare the results found from regularly active individuals to that of

sedentary and how that affects the production of BDNF post-exercise. It as well would
be interesting to compare two groups of elderly adults, one group exercising at lowintensity while the other exercises at high-intensity to see the effects of exercise intensity

on BDNF production and short-term and long-term cognitive function. There is a need
for further exploration as to how BDNF reacts with estrogen, testosterone and other

factors that could potentially influence BDNF production.

Limitations
All participants in the study were regularly active males and females. Activity

role does play a role, as found by Adlard et al. (2004), on BDNF levels and could even

play a role on cognitive performance. Within this study riding either a recumbent or
stationary bike were the only forms of aerobic exercise used. The mode of exercise itself
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was low intensity and low impact, and potentially an even lower or higher intensity

would have elicited different BDNF and cognitive results. Other forms of aerobic
exercise like that of running or swimming could elicit a different response both in BDNF
levels and cognitive performance. The only cognitive test used in the study was the

Stroop Test, possibly another cognitive assessment could have examined a different
aspect of cognition. The study had a small sample size. Although it was controlled to the
best of the researcher’s ability, the lab that the participants exercised and took the Stroop

Test in had a constantly changing environment with people coming in and out of the
room and temperature changing that could have had an effect on results. Diet was not

controlled other than that of fasting.
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APPENDIX A: INFORMED CONSENT

Cleveland State University
College of Education and Human Services
Department ofHealth and Human Performance

INFORMED CONSENT FOR PARTICIPATION
IMPACT OF GENDER ON ACUTE EXERCISE INDUCED BRAIN-DERIVED
NEUROTROPHIC FACTOR AND COGNITIVE FUNCTION IN OLDER ADULTS

Introduction
Thank you for your interest in this study. My name is Madison Phillips and I am
working on my Master’s Thesis at Cleveland State University. This study will be led
under the supervision of Dr. Emily Kullman, Associate Professor of Exercise Science in
Health and Human Performance, Dr. Kenneth Sparks, Associate Professor of Exercise
Science in Health and Human Performance, and Dr. Douglas Wajda, Associate Professor
of Exercise Science in Health and Human Performance.
The purpose of this study is to examine the impact of gender on the effect of acute
aerobic exercise on brain-derived neurotrophic factor (BDNF) and cognition among older
individuals. We will look at BDNF, estrogen, testosterone levels and cognition. BDNF is
a protein that helps protect neurons. This study will provide information on how aerobic
exercise effects BDNF levels and cognition. The research study will be conducted in the
Human Performance Laboratory (HPL) at Cleveland State University (CSU).
Procedures
BDNF, estrogen, and testosterone will be measured through blood draws from
your arm. Cognition will be measured using the Stroop test. For this test, you will be
shown color words in a different ink than the actual text. You will name the color of the
ink of each word as quickly and accurately as possible. We will recruit 10 healthy female
and 10 healthy male subjects, who regularly exercise. Subjects will complete an
American Heart Association/American College of Sports Medicine questionnaire to
determine medical history. The information will be used to determine eligibility for the
study. A test will be given as well to assess if there is delayed cognition (TICS-M).
You will be asked to come to the HPL 2-3 separate times. Each session will last
about 1.5-2 hrs and will require a 10 hour fast prior to testing. The total study time
commitment is around 4.5-6 hrs spread over 2 weeks. During session one, basic
measurements will be taken. These include height, weight, BMI, body composition,
resting heart rate, and blood pressure. You will be allowed to practice the Stroop test. We
will measure body composition using the BodPod. The BodPod is a machine that
measures your body composition comfortably by air pressure in a locked cubicle and
takes 5 minutes to complete. You will be asked to dress in a bathing suit, or form-fitting
clothes.
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The order of the last two sessions will be random. One session will be 30 minutes of
biking at 75% of age-predicted max heart rate. The other will be a reading session. A
blood sample and Stroop test will be obtained before, immediately after, and 30 minutes
after each trial. There will be a total of 3, 10 mL blood draws for each exercise session. A
total of 30 mL of blood per session. All storage and analysis of blood will be done at the
HPL by study personnel and not used for genetic testing. Those taking blood are Dr.
Emily Kullman, Dr. Kenneth Sparks, or Dr. Douglas Wajda, all trained phlebotomists.
will be done at the same time of day.
Risks
Risks of these tests are minimal and do not exceed those of normal exercise. Risks
associated with this study include muscle soreness, shortness of breath, fatigue, heart
attack, or acute injuries resulting from the exercise. This risk would be the same
experienced from a normal exercise routine. The needle stick may hurt. There is also a
small risk of bruising, a rare risk of infection, or lightheadedness. Every effort will be
made to minimize these risks. Understand that the laboratory is equipped with an
Automated External Deregulator (AED). All lab personnel are certified in CPR and First
Aid. Emergency procedures include calling EMS (x911) stating to the dispatcher: “We
have a medical emergency in the Human Performance Laboratory PE Building-Room
B60”. Cardiopulmonary Resuscitation (CPR)/First aid will be administered until EMS
arrives. In the event you are injured as a result of participation in this research, please
notify the research team and seek medical attention by your primary care physician. The
costs of such medical care will be billed to you or your insurance company. There are no
plans to provide compensation for lost wages, direct or indirect losses. Cleveland State
University will not voluntarily provide compensation for research related injury.
Understand that you can stop at any time.
Benefits
I understand that there are no direct benefits for participating in the study other
than engaging in an exercise session and body composition. However, the results of this
study will be beneficial to individuals seeking to improve their brain health through
exercise.
Confidentiality
To protect privacy, any data and information obtained will be confidential. It will
not be disclosed to anyone without consent. A number will be assigned to each subject in
place of a name. The information may be used for a statistical or scientific purpose with
the right of privacy retained. Dr. Emily Kullman and Madison Phillips will be the only
witnesses of the information being presented. Data will be stored in the Human
Performance Lab PE-60B in a locked filing cabinet. Blood samples will be unidentifiable
when in the locked cabinet and will be kept for 3 years for potential future research.
Participation
I understand that participation in this project is by choice. I have the right to
withdraw at any time with no consequences. I attest and verify that I have no known
health problems that could prevent me from completing the testing. If I have any
questions about the procedures, I can contact Dr. Emily Kullman at (216) 687-4854 or
Madison Phillips at (419) 577-5195.
I understand that if I have any questions about my rights as a research subject, I
can contact Cleveland State University’s Review Board at (216) 687-3630.
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Participant Acknowledgement
The procedures, purposes, known discomforts and risks, possible benefits to me
and to others have been explained to me. I have read the consent form and I understand it.
I also understand that all data will be stored in a secured file in the HPL for at least 3
years then shredded.
I agree to participate in this study and that I am at least 18 years old. I have also been
given a copy of this consent form.
Signature: Date:

Name Printed:____________________________
Witness: Date:
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APPENDIX B: AHA/ACSM PRESCREENING QUESTIONNAIRE
AHA/ACSM Health/Fitness Facility Preparticipation Screening Questionnaire
Assess your health status by marking all true statements

History
You have had:
___ a heart attack
___ heart surgery
___ cardiac catheterization
___ coronary angioplasty (PTCA)
___ pacemaker/implantable cardiac
___ defibrillator/rhythm disturbance
___ heart valve disease
___ heart failure
___ heart transplantation
___ congenital heart disease

If you marked any of these statements
in this section, consult your physician
or other appropriate health care provider
before engaging in exercise. You may need
to use a facility with a medically qualified

Symptoms

staff.

___ You experience chest discomfort with exertion.
___ You experience unreasonable breathlessness.
___ You experience dizziness, fainting, or blackouts.
___ You take heart medications.

Other health issues
___ You have diabetes.
___ You have asthma or other lung disease.
___ You have burning or cramping sensation in your lower
legs when walking short distances.
___ You have musculoskeletal problems that limit your
physical activity.
___ You have concerns about the safety of exercise.
___ You take prescription medication(s).
___ You are pregnant.

Cardiovascular risk factors
___ You are a man older than 45 years.
___ You are a woman older than 55 years,
have had a hysterectomy, or are postmenopausal.
___ You smoke, or quit smoking within the previous 6 months.
___ Your blood pressure is >140/90 mm Hg.
___ You do not know your blood pressure.
___ You take blood pressure medication.
___ Your blood cholesterol level is > 200 mg/dL.
___ You do not know your cholesterol level.
___ You have a close blood relative who had a heart attack
or heart surgery before age 55 (father or brother) or age
65 (mother or sister).
___ You are physically inactive (i.e., you get <30 minutes of
physical activity on at least 3 days per week).
___ You are > 20 pounds overweight.

If you marked two or more of the statements
in this section you should consult your
physician or other appropriate health care
provider before engaging in exercise. You
might benefit from using a facility with a
professionally qualified exercise staff to
guide your exercise program.

You should be able to exercise safely
without consulting your physician or other
appropriate health care provider in a self
guided program or almost any facility that
meets your exercise program needs.

___ None of the above
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APPENDIX C: TICS-M QUESTIONNAIRE

TICS-M

Orientation (1 pt each)
1. (i) What day of the week is it?
(ii) What is today’s date?
(iii) What season are we in?
2. What is your age?
3. What is your telephone number?

___Day of the week
___Day ___Month ___Year
___Season
___Age
___Telephone Number

Registration/Free Recall (1 pt each)
4. I’m going to read you a list of 10 words.
Please listen carefully and try to remember
them. When I’m done, tell me as many as
you can in any order. Ready?
Now tell me all the words you remember.

Attention/Calculation
5. Please take 7 away from 100.
Now continue to take 7 away from
what you have left over until I ask
you to stop. (1 pt each)
6. Please count backwards from 20 to 1 (2 pts)

___Cabin
___Pipe
___Elephant
___Chest
___Silk

___93
___86
___79

___Watch
___Whip
___Pillow
___Giant
___Theatre

___72
___65

___No Mistakes

Comprehension, Semantic, and Recent Memory (2 pts each)
7. What do people usually use to cut paper?
___ Scissors
8. What is the prickly green plant found in the desert? ___ Cactus
9. Who is the president now?
___Correct Name
10. Who is the vice president now?
___Correct Name
11. What is the opposite of east?
___West
Language/Repetition
12. Pleas say this: “Methodist Episcopal” (2 pts) __Exactly Right

Delayed Recall (1 pt each)
13. Please repeat the list of 10 words I read earlier

ID_______________Date_______________
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___Cabin
___Pipe
___Elephant
___Chest
___Silk

___Theatre
___Watch
___Whip
___Pillow
___Giant

___/ 46, Minimum of 31

APPENDIX D: RECRUITMENT FLYER
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APPENDIX E: STROOP TEST

In the following trials you will see words presented in different colors.
Your task is to indicate the COLOR in which each word is printed in while
ignoring what the words actually say.

Indicate the color of the word by pressing either of the following keys:
- d for red words
- f for green words
- j for blue words
- k for black words

Example: if you see the word RED printed in the color GREEN press T for green
words regardless of the meaning of the word.
Try to respond as quickly and accurately as you can, because you will be timed. If
an incorrect response is made, a red X will be flashed on the screen.
Place your index and middle fingers on the'd', 'f', 'j', and 'k' keys so that you are
ready to respond.
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APPENDIX F: INSTITUTIONAL REVIEW BOARD APPROVAL LETTER

June 13, 2019

Dear Emily Kullman,

RE: IRB-FY2019-228
IMPACT OF GENDER ON ACUTE AEROBIC EXERCISE INDUCED BRAINDERIVED NEUROTROPHIC FACTOR AND COGNITIVE FUNCTION IN THE
ELDERLY

The IRB has reviewed and approved your application for the above named project under
the category noted below.
Application renewal is not necessary unless indicated below.
Approval Category: Expedited Category 2a, 4, 7
Approval Date:
June 13, 2019
Expiration Date:
-

By accepting this decision, you agree to notify the IRB of: (1) any additions to or changes
in procedures for your study that modify the subjects’ risk in any way; and (2) any events
that affect that safety or well-being of subjects. Notify the IRB of any revisions to the
protocol, including the addition of researchers, prior to implementation.

Thank you for your efforts to maintain compliance with the federal regulations for the
protection of human subjects. Please let me know if you have any questions.
DO NOT REPLY TO THIS EMAIL. IF YOU WISH TO CONTACT US, PLEASE
SEND AN EMAIL MESSAGE TO cayuseirb@csuohio.edu.

Sincerely,

Mary Jane Karpinski
IRB Analyst
Cleveland State University
Sponsored Programs and Research Services
(216) 687-3624
m.karpinski2@csuohio.edu
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